Erratum to 'Major advancements in metastatic breast cancer treatment: when expanding options means prolonging survival': [ESMO Open Volume 7, Issue 2, April 2022, 100409]

Affiliations

¹ Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova.
² Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova; Division of Oncology 2, Istituto Oncologico Veneto IRCCS, Padova, Italy.
³ Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova; Division of Oncology 2, Istituto Oncologico Veneto IRCCS, Padova, Italy. Electronic address: valentina.guarneri@unipd.it.

Published Erratum

F Miglietta et al. ESMO Open. 2022 Jun.

. 2022 Jun;7(3):100472.

doi: 10.1016/j.esmoop.2022.100472. Epub 2022 Apr 7.

¹ Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova.
² Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova; Division of Oncology 2, Istituto Oncologico Veneto IRCCS, Padova, Italy.
³ Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova; Division of Oncology 2, Istituto Oncologico Veneto IRCCS, Padova, Italy. Electronic address: valentina.guarneri@unipd.it.

No abstract available

Erratum for

Major advancements in metastatic breast cancer treatment: when expanding options means prolonging survival.
Miglietta F, Bottosso M, Griguolo G, Dieci MV, Guarneri V. Miglietta F, et al. ESMO Open. 2022 Apr;7(2):100409. doi: 10.1016/j.esmoop.2022.100409. Epub 2022 Feb 26. ESMO Open. 2022. PMID: 35227965 Free PMC article. Review.